Course Preview

  • Nursing
  • Advanced Practice Nursing
Hours: 5 Contact Hours (5 Pharm Hours)
Author(s): David S. Roffman, BS Zoology, BS Pharmacy, PharmD, BCPS, AQ Cardiology
Peer Reviewer(s):
  • Latanja L. Divens, DNP, APRN, FNP-BC
  • Abir Kanaan, PharmD, RPh
Item#: N1744
Contents: 1 Course Book (116 pages)
Choose the best WS365 Online Nursing Membership for you:
Basic Membership – Access to 1-15 hour courses
PREMIUM Membership – Access to ALL nursing course

Cardiovascular Pharmacology, 3rd Edition

Price $27.95
Item # N1744
High-Level Content
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Release Date: December 27, 2016

Expiration Date: December 31, 2019


According to data from the Center for Disease Control, 610,000 people die from heart disease in the United States annually.  One in every four deaths is due to cardiovascular disease. There are also 12 million yearly visits to physician’s offices and close to 4 million hospital discharges for cardiovascular disease. Treatment of cardiovascular disease and monitoring for therapeutic efficacy and side effects of the drugs used require a sound knowledge of the pharmacology of these agents.

Ongoing education is needed to keep pace with these evolving changes and to equip nursing professionals with the necessary knowledge and skills to implement the most recent advances in treatment. Nurses have an important responsibility in caring for patients who are receiving these medications. Knowledge of cardiovascular medications, their effects on the body, and their administration; assessment of therapeutic and adverse effects; and patient education are essential. The purpose of this course is to provide an overview of cardiovascular pharmacology. With an ever-increasing number of patients living longer, quality nursing care for those receiving drugs for cardiovascular disease will make this knowledge critical. 



Kentucky APRNs - fulfills pharmacology requirement



Course Objectives

  • Recall the basic structures of the heart and their physiological functions.
  • Discuss ways medications are used to regulate vascular tone and improve cardiac output.
  • Describe the key pharmacological agents used to prevent and treat ischemic heart disease and cardiac rhythm disturbances.


David S. Roffman, BS Zoology, BS Pharmacy, PharmD, BCPS, AQ Cardiology, is professor emeritus at the School of Pharmacy, University of Maryland. Dr. Roffman taught much of the cardiovascular therapeutics curriculum in both the didactic and experiential portions of the curriculum during his 45-year tenure at the school. He was recognized as Teacher of the Year on six occasions by students or faculty at the school, and in 2010, he was honored as Teacher of the Year for Founders Week at the University of Maryland Baltimore Campus. In addition to his efforts at the School of Pharmacy, Dr. Roffman taught in the Cardiology Module of the Pathophysiology, Pharmacology, and Therapeutics course at the University of Maryland School of Medicine as well as the Nursing Pharmacology course at the School of Nursing. He served as the therapeutic consultant to the Cardiac Care Unit and the Progressive Care Cardiac Unit at the University of Maryland Medical System for more than 40 years. Dr. Roffman was one of the original 17 specialty cardiology pharmacy practitioners in the United States to receive added qualifications in cardiology by the Board of Pharmacy Specialties.


Latanja L. Divens, DNP, APRN, FNP-BC, is an instructor of nursing in both the undergraduate and graduate nursing programs at Louisiana State University Health Sciences Center. Dr. Divens earned a Bachelor of Science degree in biology from Xavier University of Louisiana (1996) and a Bachelor of Science in nursing degree from Our Lady of Holy Cross College (2001). She also received her master’s degree in nursing as a family nurse practitioner (2007) and the Doctor of Nursing Practice degree (2012) from Loyola University New Orleans. She is board certified by the American Nurses Credentialing Center as a primary care family nurse practitioner (FNP) and has been in this role for 9 years. As an FNP, Dr. Divens has had extensive experience in the areas of family practice, nephrology, and gastroenterology. Her passion lies in caring for patients with chronic diseases and serving underserved populations.

Abir Kanaan, PharmD, RPh, is a professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences (MCPHS). She joined the university in 2005 after completing a postgraduate pharmacy practice residency at Umass Memorial Medical Center in Worcester, Massachusetts. Dr. Kanaan also holds an adjunct faculty position in the Department of Medicine at the University of Massachusetts Medical School. In addition, she is affiliated with the Meyers Primary Care Institute, where she is involved in several research projects pertaining to medication safety in the outpatient setting. Dr. Kanaan also serves as a codirector and preceptor for the pharmacy fellowship program in Medication Safety, Quality and Informatics at Saint Vincent Hospital in Worcester. Dr. Kanaan is also the Postgraduate Education Committee program coordinator for the Worcester and Manchester campuses at MCPHS. Dr. Kanaan’s practice site is Saint Vincent Hospital in the Coronary Intensive Care Unit. She also started and currently leads the hospital’s anticoagulation monitoring program. Dr. Kanaan was appointed vice chair of the Department of Pharmacy Practice in July 2016.

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.